Fumaric Acid

Fumaric Acid

SCHEMBL7641588

Brc1cncc(CCc2c[nH]cn2)c1.O=C(O)/C=C/C(=O)O

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ HCAR2 Q8TDS4 2/20 0.35
▸ POLB P06746 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ HTT P42858 2/20 0.32
▸ MAPT P10636 1/20 0.32
▸ ALOX15 P16050 1/20 0.31
▸ MGMT P16455 1/20 0.31
▸ HCRTR1 O43613 1/20 0.31
▸ HCRTR2 O43614 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL7641601 1.00 HCAR2 (0.35) HCAR2POLBSMN1; SMN2KDM4EHTT
Fumaric Acid SCHEMBL7641574 0.89 HCAR2 (0.36) HCAR2POLBSMN1; SMN2KDM4EHTT
Fumaric Acid SCHEMBL7641580 0.89 HCAR2 (0.36) HCAR2POLBSMN1; SMN2KDM4EHTT
Fumaric Acid SCHEMBL7809151 0.73 ADRA1D (0.33) —
Fumaric Acid SCHEMBL7809161 0.73 ADRA1D (0.33) —
Maleic Acid SCHEMBL2138427 0.73 KDM4E (0.33) KDM4E
Histamine SCHEMBL2134035 0.72 TDP1 (0.38) SMN1; SMN2KDM4E
Histamine SCHEMBL27177427 0.71 TDP1 (0.37) SMN1; SMN2KDM4E
Fumaric Acid SCHEMBL7641587 0.70 POLB (0.35) HCAR2POLBKDM4EHTTMAPT
Fumaric Acid SCHEMBL7641596 0.70 POLB (0.35) HCAR2POLBKDM4EHTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6465486-B1 ALPHA2 ADRENOCEPTOR MODULATORS; HYPERTENSION, GLAUCOMA, SEXUAL DYSFUNCTION, DEPRESSION, ATTENTION DEFICIT HYPERACTIVITY DISORDER, PARKINSONISM, NEED FOR ANESTHESIA, CARDIAC ARRYTHMIA ORTHO-MCNEIL PHARMACEUTICAL, INC. 2002-10-15 — — US disclosed
Send feedback